Professor Robert Hill, chair of dental physical sciences at Queen Mary University of London, has received the Varshneya Award for his pioneering research into halogen bioactive glasses for dental applications.
Commercialisation Executive, Eleftheria Ledaki is part of a panel at the UIIN conference in Helsinki.
Head of technology transfer BioPharma : Michele Hill- Perkins has co-authored a case study with 3rd Street, a Cedars-Sinai Technology Ventures established company: Non-invasive biomarker test for detection of pancreatic ductal adenocarcinoma (PDAC).
The pioneering work of a Queen Mary researcher has been celebrated with a stamp as part of a new series launched by Royal Mail.
Queen Mary Innovation Ltd and Barts Health hosted the annual Barts Health Innovation in Healthcare Awards. The expert judging panel evaluated a plethora of high quality applications in the following categories Innovation of the Year, Dragon’s den Style Award, Collaboration Award-Barts and QMUL and Service Improvement Award.
If you would like to find out more information about our technologies or have any queries, please contact the relevant team member using our contact information found on our team profiles.